 |
市場調查報告書
商品編碼
1465587
無菌過濾市場規模- 按產品類型（過濾器、配件）、按膜類型（PES、PVDF、尼龍、PTFE、MCE）、按孔徑、按應用、按疏水性（親水、疏水）、按最終用途和全球預測，2024 - 2032Sterile Filtration Market Size - By Product Type (Filters, Accessories), By Membrane Type (PES, PVDF, Nylon, PTFE, MCE), By Pore Size, By Application, By Hydrophobicity (Hydrophilic, Hydrophobic), By End-use & Global Forecast, 2024 - 2032 |
||||||
從 2024 年到 2032 年，全球無菌過濾市場將以 9% 的複合年成長率成長。此外，持續的技術進步正在提高過濾效率和產品品質。再加上頻繁推出滿足不同產業需求的新產品，這些因素將推動無菌過濾產業的大幅成長，為製藥、生物技術和醫療保健產業提供增強的解決方案。
例如，2023 年 4 月，Porvair 推出了 Biofil(TM) 3 和 Biofil(TM) 3 Plus 系列，其中包括專為無菌液體過濾應用量身定做的聚醚碸產品。
根據產品類型、薄膜類型、孔徑、應用、疏水性、最終用途和區域進行細分。
生技公司細分市場將在 2024 年至 2032 年間顯著成長。隨著生物製藥的需求持續激增，這些公司處於創新的前沿。由於高度重視品質控制和監管合規性，生技公司將引領市場，凸顯其在醫療保健和製藥領域的關鍵地位。
到 2032 年，PVDF 領域的無菌過濾市場規模將出現可觀的成長，因為 PVDF 薄膜具有出色的耐化學性和耐用性，使其成為製藥和生物技術行業關鍵過濾製程的理想選擇。隨著對高性能過濾解決方案的需求不斷成長，PVDF 薄膜因其保持產品完整性並滿足嚴格監管要求的能力而脫穎而出。憑藉其廣泛的應用和卓越的性能，PVDF 領域將在無菌過濾行業中佔據主導地位。
由於強勁的工業成長和蓬勃發展的製藥產業，亞太地區無菌過濾產業從 2024 年到 2032 年將呈現顯著的複合年成長率。該地區不斷擴大的生物技術產業符合嚴格的監管標準，將推動這一成長。在大量創新投資的推動下，中國和印度等領先經濟體在市場上處於領先地位。隨著應用範圍涵蓋製藥、食品和飲料行業，亞太地區將成為市場擴張的關鍵貢獻者。
目錄
第 1 章：方法與範圍
第 2 章：執行摘要
第 3 章：產業洞察
- 產業生態系統分析
- 產業影響力
- 成長動力
- 藥物開發中無菌過濾的需求不斷成長
- 技術進步
- 感染預防和控制措施日益受到關注
- 私人和公共研發投資不斷增加
- 產業陷阱與挑戰
- 嚴格的監管指引
- 無菌過濾器成本高
- 成長動力
- 成長潛力分析
- 波特的分析
- PESTEL分析
- 2023 年定價分析
- 監管環境
- 技術景觀
- 未來市場趨勢
第 4 章：競爭格局
- 介紹
- 公司矩陣分析
- 公司市佔率分析
- 競爭定位矩陣
- 戰略儀表板
第 5 章：市場估計與預測：按產品類型，2018 年 - 2032 年
- 主要趨勢
- 過濾器
- 薄膜過濾器
- 筒式過濾器
- 囊式過濾器
- 注射式過濾器
- 瓶頂過濾器
- 其他過濾器類型
- 配件
第 6 章：市場估計與預測：按膜類型，2018 年 - 2032 年
- 主要趨勢
- 聚醚碸 (PES)
- 聚偏二氟乙烯 (PVDF)
- 尼龍
- 聚四氟乙烯聚合物（PTFE）
- 混合纖維素酯 (MCE)
- 其他膜類型
第 7 章：市場估計與預測：按孔徑，2018 - 2032
- 主要趨勢
- <0.1微米
- 0.1 - 0.22微米
- 0.45 - 1微米
- >1微米
第 8 章：市場估計與預測：按應用分類，2018 - 2032
- 主要趨勢
- 生物過程
- 原料過濾
- 預過濾
- 活性藥物成分過濾
- 最終產品加工
- 其他應用
第 9 章：市場估計與預測：按疏水性分類，2018 - 2032
- 主要趨勢
- 親水性膜
- 疏水膜
第 10 章：市場估計與預測：按最終用途，2018 - 2032 年
- 主要趨勢
- 製藥公司
- 生技公司
- 食品飲料公司
- CMO 和 CRO
- 其他最終用戶
第 11 章：市場估計與預測：按地區分類，2018 年 - 2032 年
- 主要趨勢
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
- 亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
- 中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區
第 12 章：公司簡介
- 3M Company
- Alfa Laval
- Cobetter Filtration Equipment Co. Ltd.
- Corning Incorporated
- Danaher Corporation
- GE Healthcare
- Merck KGaA
- Parker Hannifin Corporation
- Porvair Filtration Corp
- Sartorius AG
- Sterlitech Corporation
Global Sterile Filtration Market will grow at a 9% CAGR from 2024 to 2032. Increasing healthcare expenditure worldwide, especially in emerging markets, is creating a higher demand for sterile filtration products. Additionally, ongoing technological advancements are improving filtration efficiency and product quality. Coupled with frequent new product launches catering to diverse industry needs, these factors will drive substantial growth in the sterile filtration industry, offering enhanced solutions for the pharmaceutical, biotechnology, and healthcare sectors.
For instance, in April 2023, Porvair introduced the Biofil(TM) 3 and Biofil(TM) 3 Plus series, featuring polyethersulfone products tailored for sterile liquid filtration applications.
The is segmented based on product type, membrane type, pore size, application, hydrophobicity, end use, and region.
The biotechnology companies segment will undergo a significant uptick between 2024 and 2032. This dominance stems from their critical role in developing advanced therapies and medicines, necessitating stringent filtration processes for product safety and efficacy. As the demand for biopharmaceuticals continues to surge, these firms are at the forefront of innovation. With a strong emphasis on quality control and regulatory compliance, biotechnology companies will lead the market, highlighting their pivotal position in the healthcare and pharmaceutical sectors.
The sterile filtration market size from the PVDF segment will witness commendable growth through 2032, owing to the exceptional chemical resistance and durability of PVDF membranes, making them ideal for critical filtration processes in the pharmaceutical and biotechnology industries. As demand rises for high-performance filtration solutions, PVDF membranes stand out for their ability to maintain product integrity and meet stringent regulatory requirements. With its wide range of applications and superior performance, the PVDF segment will dominate the sterile filtration industry.
Asia Pacific sterile filtration industry will exhibit a noteworthy CAGR from 2024 to 2032, attributed to robust industrial growth and a burgeoning pharmaceutical landscape. The region's expanding biotech sector, in line with stringent regulatory standards, will propel this ascent. Leading economies such as China and India spearhead the market, fueled by substantial investments in innovation. With applications spanning pharmaceuticals to the food and beverage industries, Asia Pacific will emerge as a pivotal contributor to the market expansion.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definition
- 1.2 Base estimates & calculations
- 1.3 Data collection
- 1.4 Forecast parameters
- 1.5 Data validation
- 1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
- 1.6.2.1 Paid sources
- 1.6.2.2 Public sources
Chapter 2 Executive Summary
- 2.1 Industry 360 degree synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Growing demand for sterile filtration in drug development
- 3.2.1.2 Technological advancements
- 3.2.1.3 Increasing concern for infection prevention and control measures
- 3.2.1.4 Rising private and public investment in research and development
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Stringent regulatory guidelines
- 3.2.2.2 High cost of sterile filters
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Porter's analysis
- 3.4.1 Supplier power
- 3.4.2 Buyer power
- 3.4.3 Threat of new entrants
- 3.4.4 Threat of substitutes
- 3.4.5 Industry rivalry
- 3.5 PESTEL analysis
- 3.6 Pricing analysis, 2023
- 3.7 Regulatory landscape
- 3.8 Technological landscape
- 3.9 Future market trends
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Filters
- 5.2.1 Membrane filters
- 5.2.2 Cartridge filters
- 5.2.3 Capsule filters
- 5.2.4 Syringe filters
- 5.2.5 Bottle-top filters
- 5.2.6 Other filter types
- 5.3 Accessories
Chapter 6 Market Estimates and Forecast, By Membrane Type, 2018 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Polyethersulfone (PES)
- 6.3 Polyvinylidene fluoride (PVDF)
- 6.4 Nylon
- 6.5 Polytetrafluoroethylene polymer (PTFE)
- 6.6 Mixed cellulose esters (MCE)
- 6.7 Other membrane types
Chapter 7 Market Estimates and Forecast, By Pore Size, 2018 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 <0.1μm
- 7.3 0.1 - 0.22μm
- 7.4 0.45 - 1μm
- 7.5 >1μm
Chapter 8 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 Bioprocess
- 8.3 Raw material filtration
- 8.4 Prefilteration
- 8.5 Active pharmaceutical ingredient filtration
- 8.6 Final product processing
- 8.7 Other applications
Chapter 9 Market Estimates and Forecast, By Hydrophoicity, 2018 - 2032 ($ Mn)
- 9.1 Key trends
- 9.2 Hydrophilic membrane
- 9.3 Hydrophobic membrane
Chapter 10 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)
- 10.1 Key trends
- 10.2 Pharmaceutical companies
- 10.3 Biotechnology companies
- 10.4 Food & beverage companies
- 10.5 CMOs & CROs
- 10.6 Other end-users
Chapter 11 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)
- 11.1 Key trends
- 11.2 North America
- 11.2.1 U.S.
- 11.2.2 Canada
- 11.3 Europe
- 11.3.1 Germany
- 11.3.2 UK
- 11.3.3 France
- 11.3.4 Spain
- 11.3.5 Italy
- 11.3.6 Rest of Europe
- 11.4 Asia Pacific
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 Australia
- 11.4.5 South Korea
- 11.4.6 Rest of Asia Pacific
- 11.5 Latin America
- 11.5.1 Brazil
- 11.5.2 Mexico
- 11.5.3 Argentina
- 11.5.4 Rest of Latin America
- 11.6 Middle East and Africa
- 11.6.1 South Africa
- 11.6.2 Saudi Arabia
- 11.6.3 UAE
- 11.6.4 Rest of Middle East and Africa
Chapter 12 Company Profiles
- 12.1 3M Company
- 12.2 Alfa Laval
- 12.3 Cobetter Filtration Equipment Co. Ltd.
- 12.4 Corning Incorporated
- 12.5 Danaher Corporation
- 12.6 GE Healthcare
- 12.7 Merck KGaA
- 12.8 Parker Hannifin Corporation
- 12.9 Porvair Filtration Corp
- 12.10 Sartorius AG
- 12.11 Sterlitech Corporation
